Karsten Hufendiek
Overview
Explore the profile of Karsten Hufendiek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
317
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Konen F, Mohn N, Witte T, Schefzyk M, Wiestler M, Lovric S, et al.
Autoimmun Rev
. 2025 Jan;
24(4):103754.
PMID: 39842533
A wide variety of immunomodulatory therapies are already available for the treatment of multiple sclerosis (MS). Through fundamental insights from basic research with a gain of knowledge in the pathological...
2.
Kiel C, Biasella F, Stohr H, Rating P, Spital G, Kellner U, et al.
Sci Rep
. 2024 Oct;
14(1):25529.
PMID: 39462066
Inherited retinal dystrophies (IRDs) and inherited optic neuropathies (IONs) are characterized by distinct genetic causes and molecular mechanisms that can lead to varying degrees of visual impairment. The discovery of...
3.
Langer F, Binter M, Hu X, Hufendiek K, Meister R, Tode J, et al.
Sci Rep
. 2024 Sep;
14(1):22002.
PMID: 39313534
The trabecular meshwork (TM) is crucial for regulating intraocular pressure (IOP), and its dysfunction significantly contributes to glaucoma, a leading cause of vision loss and blindness worldwide. Although rodents are...
4.
Pfeil J, Barth T, Lagreze W, Lorenz B, Hufendiek K, Liegl R, et al.
Ophthalmol Retina
. 2023 Dec;
8(6):579-589.
PMID: 38104929
Purpose: To analyze changes in demographic parameters and retreatment patterns over a 10-year period in a clinical routine setting of infants with retinopathy of prematurity (ROP) requiring treatment documented in...
5.
Lindziute M, Kaufeld J, Hufendiek K, Volkmann I, Brockmann D, Hosari S, et al.
Orphanet J Rare Dis
. 2023 Oct;
18(1):314.
PMID: 37807078
Background: The goal of this study was to evaluate macular microvascular changes in patients with Fabry disease (FD) using optical coherence tomography angiography (OCTA) and to explore their correlation with...
6.
Hufendiek K, Bredt M, Binter M, Rosenstein C, Greb O, Wiezorrek M, et al.
Ophthalmol Ther
. 2023 Sep;
12(6):3233-3249.
PMID: 37773478
Introduction: In this work, we provide a detailed characterization of a rare complication-subconjunctival cyst formation after strabismus surgery-in a large German cohort. Methods: We conducted a retrospective analysis of 822...
7.
Hufendiek K, Lindziute M, Kaufeld J, Volkmann I, Brockmann D, Hosari S, et al.
Ophthalmol Ther
. 2023 Aug;
12(5):2713-2727.
PMID: 37542614
Introduction: Retinal microvasculature is known to be altered in patients with Fabry disease (FD). We aimed to investigate the long-term changes in macular microvasculature and explore a reliable retinal biomarker...
8.
Farassat N, Bohringer D, Kuchlin S, Molnar F, Schwietering A, Seger D, et al.
BMJ Open
. 2023 Apr;
13(4):e068822.
PMID: 37080623
Introduction: Myopia is a major cause of degenerative eye disease and increases the risk of secondary visual impairment. Mitigating its progression therefore has great potential of clinically relevant benefit as...
9.
Konen F, Mohn N, Witte T, Schefzyk M, Wiestler M, Lovric S, et al.
Autoimmun Rev
. 2023 Mar;
22(5):103312.
PMID: 36924922
More than 10 disease-modifying therapies (DMT) are approved by the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) for the treatment of multiple sclerosis (MS) and...
10.
Gerhardt M, Priglinger C, Rudolph G, Hufendiek K, Framme C, Jagle H, et al.
Biomedicines
. 2023 Jan;
11(1).
PMID: 36672611
Leber congenital amaurosis caused by mutations in the RPE65 gene belongs to the most severe early-onset hereditary childhood retinopathies naturally progressing to legal blindness. The novel gene therapy voretigene neparvovec...